
Brenntag acquires mcePharma to expand GMP capabilities in biopharma services
Ella Day | June 5, 2025 | News story | Manufacturing and Production, Mergers and Acquisitions | Brenntag Specialities, Corporate, acquisition, continuous monitoring platform (CMP), mcePharma
Brenntag Specialties has acquired Czech-based mcePharma, strengthening its position in the pharma and biopharma industries through expanded continuous monitoring platform (CMP) capabilities and a more strategic presence in central Europe.
The acquisition will enable Brenntag to develop a central hub for good manufacturing practice (GMP) value-added services across Europe, the Middle East and Africa (EMEA), supporting increased demand for customised solutions in the biopharma market. Existing facilities at mcePharma include advanced GMP infrastructure and over-the-counter product development capacity. All will be integrated into Brenntag’s broader life sciences service offering.
Also, the company announced additional investment at the site to scale GMP blending, down-packing and biobuffer production. These are intended to improve operational efficiency and meet growing needs for high-quality, compliant formulation and distribution services.
“This is a powerful enhancement to our portfolio that reinforces our commitment to quality, speed and customer-centric solutions,” said Joakim Rehné, president of pharma EMEA at Brenntag.
Ivan Mikes, administration board member at mcePharma, added: “Our team will get the chance to leverage their expertise and serve the entire EMEA region together with Brenntag.”
Gust Desmedt, global president pharma at Brenntag, commented: “This acquisition represents a key milestone in our strategic initiatives to further expand our biopharma services.”
Ella Day
5/6/25

This article featured in: July 2025 – The Pharmafile Brief
Related Content

Curium Pharma announces acquisition of Monrol
Curium Pharma, a nuclear medicine company, has acquired Eczacıbaşı-Monrol Nuclear Products (Monrol), a nuclear medicine …

Enosium Life Science acquires RWEality
Enosium Life Science, which specialises in life sciences, has acquired RWEality, a consultancy focused on …

CANDOR Bioscience acquired by Medix Biochemica
CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier …






